Huang Wang shared the achievements of huami in 2019 at the meeting: as of August 27, 2019, the global intelligent equipment shipments of huami exceeded 100 million units. In terms of chips, "Huangshan No.1" independently developed by huami technology has also been applied to a number of amazfit brand watches and bracelets in mass production this year, including the current flagship product amazfit smart watch 2 ECG version.
According to Huang Wang, "Huangshan 2" has completed the overall design and will be mass produced in 2020. It said that the chip will support more intelligent and healthy functions, and will also be applied to more smart watches.
In addition, huami technology also announced a cooperation with alivecor company of the United States to expand the medical ECG service market in developed countries in Europe and the United States; at the same time, huami technology global innovation center and cardiovascular medicine department of Peking University First Hospital signed a strategic cooperation record to jointly promote the heart health management plan in China.
Previously, huami has cooperated with the Department of Cardiology of Peking University Hospital to conduct clinical research on 401 patients with 12 lead ECG as the gold standard. The results show that the accuracy of ECG and PPG of amazfit is 94.76% and 93.27%, respectively. The sensitivity, specificity and accuracy of monitoring are basically consistent with the results of artificial interpretation by professional doctors.
Finally, in terms of exploring the form of huami terminal, Huang Wang said that in the future, huami's intelligent wearable products will not be limited to watches and bracelets, but will have new categories.